Brighton Jones’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.02M Sell
291,034
-3,062
-1% -$13.6K 0.02% 517
2026
Q2
$1.59M Buy
294,096
+2,631
+0.9% +$10.1K 0.03% 361
2026
Q1
$665K Buy
+291,465
New +$925K 0.01% 584
2025
Q4
– Sell
-348,549
Closed -$2.95M – 339
2025
Q3
$2.95M Sell
348,549
-26
-0% -$252 0.07% 153
2025
Q2
$3.92M Sell
348,575
-588
-0.2% -$5.4K 0.11% 118
2025
Q1
$3.31M Buy
349,163
+54
+0% +$545 0.11% 113
2024
Q4
$3.93M Buy
+349,109
New +$6.14M 0.11% 103

Other funds holding EVH

Brighton Jones's EVH Position: Q3 2026 in Review

Brighton Jones reduced its Evolent Health (EVH) stake by 1% in Q3 2026, selling an estimated $13.6K and leaving 291,034 shares worth $1.02M. The position accounts for 0.02% of the portfolio, ranked #517.

Brighton Jones first reported a position in EVH in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.93M in Q4 2024. 193 funds tracked by Wall St. Rank hold EVH as of Q3 2026.

  • Brighton Jones held 291,034 shares of Evolent Health worth $1.02M as of Q3 2026.
  • Brighton Jones sold 3,062 Evolent Health shares in Q3 2026, an estimated $13.6K.
  • Evolent Health made up 0.02% of Brighton Jones's portfolio in Q3 2026, its #517 holding.
  • Brighton Jones first reported a position in Evolent Health in Q4 2024 and has held it in 7 quarters since.
  • Brighton Jones's Evolent Health position peaked at $3.93M in Q4 2024.
  • 193 funds tracked by Wall St. Rank held Evolent Health as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.